NICOLE NELSON: Open Payments
NPI 1164132254 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,278 in 57 payments from 12 companies in 2025. Trend: 2023 $95 · 2024 $0 · 2025 $1,278
Food & beverage: $1,278
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $395 |
| Alkermes, Inc. | 10 | $198 |
| Otsuka America Pharmaceutical, Inc. | 8 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $147 |
| Supernus Pharmaceuticals, Inc. | 4 | $72 |
| Lundbeck LLC | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
Products named: VRAYLAR, REXULTI, ARISTADA, CAPLYTA, Qelbree, TRINTELLIX, Auvelity, SPRAVATO.
Industry payments across TX — which companies pay providers there.
